About: IMPACT OF COVID-19 PANDEMIC IN THE ACTIVITY OF A THERAPEUTIC APHERESIS UNIT IN ITALY

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: IMPACT OF COVID-19 PANDEMIC IN THE ACTIVITY OF A THERAPEUTIC APHERESIS UNIT IN ITALY Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	IMPACT OF COVID-19 PANDEMIC IN THE ACTIVITY OF A THERAPEUTIC APHERESIS UNIT IN ITALY
Creator	Colpo, A Colpo, Anna De Silvestro, G Marson, P
Source	Elsevier; PMC
abstract	Abstract Introduction The recent Coronavirus Disease 2019 (COVID-19) outbreak has led to profound and rapid changes in the Italian and Veneto Region Healthcare System. This context also includes the quick reorganization which the Apheresis Unit (AU) of the Padova University Hospital, i.e. the Regional Reference Center for Therapeutic Apheresis (TA), had to face. Material and Methods The study retrospectively evaluated the TA activity (procedures performed, patients treated and consultations) during the COVID-19 pandemic, from March to April 2020, comparing the activity in the same time period in 2018 and 2019. Results In the period analyzed, a significant reduction in both the total number of procedures performed and of patients treated, respectively by 17% and 16% for the procedures and by 19% and 20% for patients treated compared to the same period of 2018 and 2019, respectively, was observed. A concomitant reduction in requests for TA consultation for new patients (both outpatients and inpatients) was observed, equal to 32% and 21% compared to 2018 and 2019, respectively. Conclusion Many reasons determined the observed reduction in the TA activity during the recent COVID-19 outbreak. The AU itself was quickly reorganized in terms of location and supplies to allow for the appropriate COVID-19 patients care. Many non urgent cases, after multidisciplinary discussion between Clinicians and Apheresis Specialists, were deferred, maintaining close phone and e-mail contact with patients.
has issue date	2020-08-25(xsd:dateTime)
bibo:doi	10.1016/j.transci.2020.102925
has license	els-covid
sha1sum (hex)	d2c3bc0cc8f91edac2346c47254587e5a2cbd154
schema:url	https://doi.org/10.1016/j.transci.2020.102925
resource representing a document's title	IMPACT OF COVID-19 PANDEMIC IN THE ACTIVITY OF A THERAPEUTIC APHERESIS UNIT IN ITALY
has PubMed Central identifier	PMC7446708
schema:publication	Transfus Apher Sci
resource representing a document's body	covid:d2c3bc0cc8f91edac2346c47254587e5a2cbd154#body_text
is schema:about of	named entity 'INTRODUCTION' named entity 'REORGANIZATION' named entity 'REGION' named entity 'Veneto' named entity 'immune-mediated disease' named entity 'immunosuppressive therapy' named entity 'March 1' named entity 'COVID-19' named entity 'Apheresis' named entity 'Apheresis' named entity 'CIDP' named entity 'Windows' named entity 'COVID-19' named entity 'Graves orbitopathy' named entity 'maternal and child health' named entity 'COVID-19' named entity 'Dermatologists' named entity 'GVHD' named entity 'COVID-19 pandemic' named entity 'oncological' named entity 'Italian' named entity 'single center' named entity 'EORTC' named entity 'COVID-19 outbreak' named entity 'complete remission' named entity 'COVID-19 outbreak' named entity 'vaso-occlusive crisis' named entity 'Haemoglobinopathy' named entity 'lung' named entity 'IVIg' named entity 'immunosuppressive' named entity 'acute chest syndrome' named entity 'Regional Health Authorities' named entity 'rescue therapy' named entity 'immune-modulating treatments' named entity 'health systems' named entity 'Atopic Dermatitis' named entity 'COVID-19 pandemic' named entity 'COVID-19' named entity 'ACS' named entity 'immune-modulating treatments' named entity 'cross-matching' named entity 'cardiovascular disease' named entity 'March 5' named entity 'COVID-19' named entity 'Hidradenitis Suppurativa' named entity 'epidemic' named entity 'stroke' named entity 'ACS' named entity 'GVHD' named entity 'SARS-CoV-2 outbreak' named entity 'GVHD' named entity 'immunosuppressed' named entity 'interstitial lung disease' named entity 'antibodies' named entity 'COVID-19 outbreak' named entity 'confidence interval' named entity 'pemphigus vulgaris' named entity 'statistically significant' named entity 'COVID-19 outbreak' named entity 'Transfusion Medicine' named entity 'partial remission' named entity 'outbreak of the Coronavirus' named entity 'ulcerative colitis' named entity 'hypertension' named entity 'rituximab' named entity 'intravenous Immunoglobulins' named entity 'GraphPad Prism' named entity 'CIDP' named entity 'pediatric patients' named entity 'respiratory failure' named entity 'FSGS' named entity 'Italy' named entity 'Endocrinologists' named entity 'ICU' named entity 'prophylaxis' named entity 'elective surgery' named entity 'Hematologists' named entity 'pediatric' named entity 'Apheresis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software